The Reds' bullpen is shaping up to be a fierce battleground this season, with a compelling narrative unfolding around Connor Phillips. Will he secure a spot in the bullpen, defying the odds after a challenging medical journey?
Phillips is in the running for a coveted role in the Cincinnati Reds' relief pitching crew, as reported by Mark Sheldon. But here's where his story takes an intriguing turn: Phillips' career path was altered by a medical condition, Thoracic Outlet Syndrome (TOS), which led to a transition from starting games to becoming a reliever.
To manage TOS, Phillips underwent a unique treatment—Botox injections. This innovative approach proved successful, enabling him to pitch effectively in shorter bursts. His performance in the latter part of the 2025 season was remarkable, showcasing a powerful combination of four-seam and sweeper pitches that left batters bewildered. In his last 17 appearances, spanning 20 innings, Phillips achieved a minuscule 1.80 ERA, striking out 28 batters while walking only eight.
And this is the part that makes Phillips' journey even more captivating: he hasn't needed those Botox injections in 2026, but they remain an option if necessary. Despite the Reds' bullpen enhancements during the offseason, Phillips is determined to claim his place. He'll be up against talented pitchers like Sam Moll, Zach Maxwell, and Luis Mey for a spot on the prestigious Opening Day roster.
Is Phillips' story a testament to the power of medical innovation in sports? Or is it a cautionary tale about the risks pitchers face? Share your thoughts on this intriguing journey and the upcoming bullpen battle in the comments!
